HK1011611A1 - Use of l-deprenyl for retarding age dependent deterioration of the immune system function in mammals - Google Patents

Use of l-deprenyl for retarding age dependent deterioration of the immune system function in mammals

Info

Publication number
HK1011611A1
HK1011611A1 HK98112656A HK98112656A HK1011611A1 HK 1011611 A1 HK1011611 A1 HK 1011611A1 HK 98112656 A HK98112656 A HK 98112656A HK 98112656 A HK98112656 A HK 98112656A HK 1011611 A1 HK1011611 A1 HK 1011611A1
Authority
HK
Hong Kong
Prior art keywords
deprenyl
mammals
immune system
system function
dependent deterioration
Prior art date
Application number
HK98112656A
Other languages
English (en)
Inventor
Norton W Milgram
David R Stevens
Gwendolyn O Ivy
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27076843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1011611(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/576,011 external-priority patent/US5151449A/en
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Publication of HK1011611A1 publication Critical patent/HK1011611A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
HK98112656A 1990-08-31 1998-12-02 Use of l-deprenyl for retarding age dependent deterioration of the immune system function in mammals HK1011611A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/576,011 US5151449A (en) 1990-08-31 1990-08-31 Use of L-deprenyl for retention of specific physiological functions
US64345291A 1991-01-18 1991-01-18

Publications (1)

Publication Number Publication Date
HK1011611A1 true HK1011611A1 (en) 1999-07-16

Family

ID=27076843

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98112656A HK1011611A1 (en) 1990-08-31 1998-12-02 Use of l-deprenyl for retarding age dependent deterioration of the immune system function in mammals

Country Status (16)

Country Link
US (2) US5276057A (de)
EP (2) EP0473252B1 (de)
JP (3) JP2819072B2 (de)
AT (2) ATE181501T1 (de)
AU (1) AU633714B2 (de)
BR (1) BR9103506A (de)
CA (1) CA2039194C (de)
DE (2) DE69124875T2 (de)
DK (2) DK0473252T3 (de)
ES (2) ES2135123T3 (de)
GR (2) GR3022971T3 (de)
HK (1) HK1011611A1 (de)
ID (1) ID19492A (de)
MX (1) MX9100067A (de)
MY (2) MY124210A (de)
NZ (1) NZ238277A (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565495A (en) * 1990-08-31 1996-10-15 Deprenyl Animal Health, Inc. Method for survival curve shifting in dogs
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
EP0578687A1 (de) * 1991-04-04 1994-01-19 The University Of Toronto Innovations Foundation Verwendung von deprenyl zur unterhaltung,verhinderung von verlust oder zurückgewinnung von nervenzellefunktion
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
US5547995B1 (en) * 1993-05-04 1998-01-27 Sanofi Elf Use of selegiline in veterinary medicine
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
CN100360123C (zh) 1995-01-13 2008-01-09 萨默塞特药品有限公司 应用去甲司来吉兰的方法和医药组合物
WO1996024346A1 (en) 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
JPH11506744A (ja) 1995-06-07 1999-06-15 ノウブン ファーマシューティカルズ インク． 室温で液体である低分子量薬を含む経皮組成物
ES2180809T5 (es) * 1995-11-06 2005-06-16 Somerset Pharmaceuticals, Inc. Administracion de selegilina sublingual y bucal.
IL138290A0 (en) 1998-03-16 2001-10-31 Somerset Pharmaceuticals Inc Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
US20030212144A1 (en) * 2001-07-18 2003-11-13 Mohankumar Sheba J.J. Method for inducing an estrous cycle and pregnancy in a female mammal
WO2004041151A2 (en) * 2002-11-07 2004-05-21 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
US20050009862A1 (en) * 2003-04-25 2005-01-13 Sabounjian Luann Method for promoting uninterrupted sleep by administration of trospium chloride
EP1686973A4 (de) * 2003-11-25 2009-03-25 Technion Res & Dev Foundation Zusammensetzungen und verfahren zur behandlung von kardiovaskulären erkrankungen und krankheiten
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
JP2005232148A (ja) * 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
US8263655B2 (en) * 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
CA2785642C (en) 2009-12-29 2014-12-02 Hill's Pet Nutrition, Inc. Compositions including pyruvate for companion animals and methods of use thereof
SG183150A1 (en) 2010-02-03 2012-09-27 Pharma Two B Ltd Extended release formulations of rasagiline and uses thereof
CN103860503A (zh) * 2012-12-10 2014-06-18 天津市汉康医药生物技术有限公司 一种治疗帕金森病的缓释药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4880883A (en) * 1987-06-03 1989-11-14 Wisconsin Alumni Research Foundation Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same

Also Published As

Publication number Publication date
GR3031263T3 (en) 1999-12-31
JP2884501B2 (ja) 1999-04-19
MX9100067A (es) 1992-04-01
DE69131386T2 (de) 1999-11-25
CA2039194A1 (en) 1992-03-01
NZ238277A (en) 1993-10-26
MY110217A (en) 1998-03-31
BR9103506A (pt) 1992-05-12
AU7395791A (en) 1992-03-05
US5387615A (en) 1995-02-07
DE69124875D1 (de) 1997-04-10
JP2884500B2 (ja) 1999-04-19
EP0473252A3 (en) 1992-08-05
DE69131386D1 (de) 1999-07-29
CA2039194C (en) 1997-01-28
EP0732101B1 (de) 1999-06-23
DK0473252T3 (da) 1997-09-15
ATE149350T1 (de) 1997-03-15
AU633714B2 (en) 1993-02-04
MY124210A (en) 2006-06-30
ES2135123T3 (es) 1999-10-16
ID19492A (id) 1998-07-16
JPH04230624A (ja) 1992-08-19
JPH09328422A (ja) 1997-12-22
EP0473252A2 (de) 1992-03-04
JPH09328423A (ja) 1997-12-22
EP0732101A1 (de) 1996-09-18
US5276057A (en) 1994-01-04
ATE181501T1 (de) 1999-07-15
ES2097790T3 (es) 1997-04-16
JP2819072B2 (ja) 1998-10-30
DK0732101T3 (da) 1999-11-22
EP0473252B1 (de) 1997-03-05
DE69124875T2 (de) 1997-06-26
GR3022971T3 (en) 1997-06-30

Similar Documents

Publication Publication Date Title
HK1011611A1 (en) Use of l-deprenyl for retarding age dependent deterioration of the immune system function in mammals
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
GB9019812D0 (en) Novel antibodies for treatment and prevention of infection in animals and man
GB2240970B (en) Animal feeder with adjustable gate
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
EP0313654A4 (de) Arzneimittel für die prophylaxe und die behandlung von leberkrankheiten.
DE3851456T2 (de) Synergetische immunostimulierende Zusammensetzung und ihre Verwendung.
EP0335704A3 (en) Treatment of equine livestock
GB2209343B (en) Preparation for prophylaxis and treatment of gastro-intestinal disturbances in farm animals
NZ220242A (en) Regulating fertility in cattle by administering epostane
AU2492892A (en) The device for treatment and prophylaxis of mastitis in animals
EP0154598A3 (en) Method and device for administering medicines or the like to aquatic animals, in particular fish
FR2636239B1 (fr) Composition desinfectante pour la prevention de la mammite subclinique chez les ruminants
ZA914219B (en) Transdermal administration to humans and animals
IT9040006A1 (it) Metodo ed apparecchiatura per l'allevamento dinamico della vite.
BG52054B2 (en) Device for parasitic disease treatment and prophylaxis
ITMN910022A1 (it) Gruppo termoventilante per l'essicazione del foraggio imballato e sciolto con dispositivo di riciclo dell'aria di essicazione
SU1448442A1 (ru) Препарат для лечения и профилактики вольфартиоза сельскохозяйственных животных
CA2113341A1 (en) Use of natamycin for the prevention and control of poultry dactylariosis
IT1171125B (it) Composizione per uso orale particolarmente destinata al trattamento terapeutico di animali
IL101277A (en) Apparatus for treating fresh fruit and the like to prevent and retard the growth of fungus
AU7392187A (en) Preparation for prophylaxis and treatment of gastro- intestinal disturbances in farm animals

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060328